Failed to connect with MySQL: User dastyarekoob_sEcAdMiNDaTa already has more than 'max_user_connections' active connections
Helicobacter pylori infection is a major cause of chronic gastritis and peptic ulcers, and persistent infection can raise the risk of gastric cancer. Early diagnosis is therefore important for starting treatment and reducing complications.
Using lateral flow technology, the Iranian company Zist-Tashkhis Sanjeh has produced a nano-based kit that detects H. pylori antigen in stool samples. The test uses a specific antibody and reports a qualitative result, positive or negative. Because sampling is non-invasive and the test is fast, simple, and relatively low-cost, the kit can be used in medical laboratories and healthcare centers for initial diagnosis and for follow-up after treatment.
Lateral flow technology allows rapid diagnostic tools that need no complex equipment, which makes it suitable for settings with limited access to advanced laboratory facilities. According to the company, its products are manufactured in line with ISO 9001:2015 and ISO 13485:2016, the quality management standard for medical devices.
The kit is available at some healthcare facilities in Iran. As with any diagnostic product, results should be interpreted according to the product instructions and the patient’s clinical condition, and its performance should be assessed against validation data, including sensitivity and specificity.